Shama Khan to Protein Kinase Inhibitors
This is a "connection" page, showing publications Shama Khan has written about Protein Kinase Inhibitors.
Connection Strength
1,154
-
Reversible versus irreversible inhibition modes of ERK2: a comparative analysis for ERK2 protein kinase in cancer therapy. Future Med Chem. 2018 05 01; 10(9):1003-1015.
Score: 0,599
-
MAP/Microtubule Affinity Regulating Kinase 4 Inhibitory Potential of Irisin: A New Therapeutic Strategy to Combat Cancer and Alzheimer's Disease. Int J Mol Sci. 2021 Oct 12; 22(20).
Score: 0,191
-
Structure-based investigation of MARK4 inhibitory potential of Naringenin for therapeutic management of cancer and neurodegenerative diseases. J Cell Biochem. 2021 10; 122(10):1445-1459.
Score: 0,187
-
PKR-inhibitor binds efficiently with human microtubule affinity-regulating kinase 4. J Mol Graph Model. 2015 Nov; 62:245-252.
Score: 0,126
-
Naringenin as a potential inhibitor of human cyclin-dependent kinase 6: Molecular and structural insights into anti-cancer therapeutics. Int J Biol Macromol. 2022 Jul 31; 213:944-954.
Score: 0,050